Immunotherapy toxicities: An SGO clinical practice statement Review


Authors: O'Cearbhaill, R. E.; Clark, L.; Eskander, R. N.; Gaillard, S.; Moroney, J.; Pereira, E.; Pothuri, B.
Review Title: Immunotherapy toxicities: An SGO clinical practice statement
Keywords: endometrial cancer; immunotherapy; toxicity; cervical cancer; programmed death 1 receptor; adverse event; checkpoint blockade; humans; human; pembrolizumab; programmed cell death 1 receptor
Journal Title: Gynecologic Oncology
Volume: 166
Issue: 1
ISSN: 10956859
Publisher: Elsevier B.V.  
Date Published: 2022-07-01
Start Page: 25
End Page: 35
Language: English
DOI: 10.1016/j.ygyno.2022.05.003
PUBMED: 35597686
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 July 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors